Early inflammation in the airways of a cystic fibrosis foetus  by Verhaeghe, Catherine et al.
6 (2007) 304–308
www.elsevier.com/locate/jcfJournal of Cystic FibrosisEarly inflammation in the airways of a cystic fibrosis foetus☆
Catherine Verhaeghe a, Katty Delbecque b, Laurence de Leval b, Cecile Oury a, Vincent Bours a,⁎
a Department of Human Genetics, Center for Biomedical Integrative Genoproteomics (CBIG), University of Liege, B-4000 Liege, Belgium
b Department of Pathology, Center for Biomedical Integrative Genoproteomics (CBIG), University of Liege, B-4000 Liege, Belgium
Received 12 October 2006; received in revised form 22 November 2006; accepted 7 December 2006
Available online 12 January 2007Abstract
In cystic fibrosis patients, inflammation is often considered to be secondary to chronic infections. In the present study, we show increased
levels of pro-inflammatory proteins in the lungs of a cystic fibrosis foetus compared to the lungs of two normal foetuses. Our findings suggest
therefore the existence of an early intrinsic pro-inflammatory state in cystic fibrosis airways.
© 2006 European Cystic Fibrosis Society. Published by Elsevier B.V. All rights reserved.Keywords: CFTR; NF-κB; Pro-inflammatory cytokines1. Introduction
Eighty to ninety percents of Cystic Fibrosis (CF) patients
succumb to respiratory failure caused by chronic bacterial
infection and concomitant airway inflammation [2]. The
sequence of events at the onset of pulmonary infection and
inflammation is controversial and not fully characterized. At
birth, the lungs of CF patients appear normal [3,4]; however,
autopsy examination of infants revealed a dilatation of acinar
and duct lumens of sub-mucosal glands due to abnormal
mucus secretion demonstrating pre-clinical signs in the very
first months of life. Several studies also described the
presence of neutrophils, elevated levels of elastase and IL-8,
in the absence of any pathogen, in broncho-alveolar lavage
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7]. Indeed, the abnormal composition of airway secretions
and/or their depletion are frequently cited as the host factors
that predisposes CF patients to chronic colonization by
P. aeruginosa and resultant inflammation. However, a recent
study [8] showed that the over-expression of the epithelial
Na+ channel ENac in mice bronchiolar epithelium reduced
the volume of preciliary liquid leading to neutrophil influx
and increased levels of IL-8 in airways. These results
indicate that inflammation can arise from disregulated ion
transport in airway epithelium in the absence of any
infection. Moreover, several reports showed in various CF
cell lines [9–12] an increased activation of the transcription
factor NF-κB, a central player in inflammation, supporting
the idea that CFTR dysfunction can by itself cause the
expression of pro-inflammatory mediators [2,5–7,13–15].
Nevertheless, very little evidence for an inflammatory state
existing before infection have been brought so far, leaving
the debate open.
2. Case report
The examination of a 24 week-old foetus after pregnancy
interruption for a hydrocephaly of unknown origin showed
pancreatic histology signs evoking CF. There was not any
sign of infection in the mother or the foetus. A genetic test
highlighted the ΔF508 mutation on both CFTR alleles anded by Elsevier B.V. All rights reserved.
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been established between hydrocephaly and cystic fibrosis.
Two foetuses were obtained after termination of the
pregnancies either for a CMV foetopathy (22 weeks of
amenorrhea) or for a Turner syndrome (23 weeks of
amenorrhea) and were used as controls. Lungs were collected
after the approval from the Institutional Review Board.
3. Methods
3.1. Immunohistochemistry and immunofluorescence
Studies were performed on paraffin-embedded material.
Primary antibodies used were anti-ICAM-1, anti-Gro-β,
anti-Gro-γ, anti-p65 (Santa-Cruz), anti-MMP1 (R and D
system, France) and anti-COX2 (Cayman, MI).
Immunohistochemistry. A three-step indirect immuno-
peroxidase technique was used with the LSAB2 kit and
DAB+(Dako) as the chromogen after heat-induced antigen
retrieval in EDTA buffer (pH 9).
Immunofluorescence. After heat-induced antigen retriev-
al in sodium citrate buffer (10 mM, pH 6), sections were
stained with primary antibody followed by incubation with
Alexa-Fluor 488 (Molecular Probes, Leiden, The Nether-
lands). For nuclear DNA staining, TOTO-3 iodide (Molec-
ular Probes) was added to the secondary antibody solution.
Confocal microscopy analyses were performed with a TCS
SP confocal microscope (Leica) as described [16].
4. Results and discussion
It is debated whether pulmonary inflammation precedes
or follows infection in CF. The lungs of patients with CF are
inflamed and infected at a young age, and it is difficult to
exclude the presence of all pathogens. Therefore, to
investigate a putative early pro-inflammatory state, immu-
nohistological studies were undertaken to compare the
expression levels of known pro-inflammatory proteins in
the lungs of a 24 week-old CF foetus homozygous for the
ΔF508-CFTR mutation and in control lungs from two
foetuses at similar development stages. Due to scarcity of
such human material, this is the first study of CF foetal lungs.
Since an early pathological hallmark of CF inflammatory
response consists of neutrophil influx into the airways,
we analysed the expression of the intracellular adhesion
molecule-1 (ICAM-1) and the chemokines Gro-β and Gro-γ,
three pro-inflammatory molecules known to be involved in
neutrophil extravasation and chemotaxis [17,18]. We also
studied the expression of the major pro-inflammatory
enzyme Cox-2 and of the matrix metalloproteinase 1
(MMP-1) that by degrading extracellular matrix proteins
may play a role in airway remodeling.
ICAM-1 expression was higher in CF bronchial epithelial
cells as compared to control non-CF foetal lung epithelia;
ICAM-1 was mainly localized at the apical membrane of these
bronchial cells (Fig. 1A and B). High ICAM-1 protein levelswere previously observed in adult CF lungs, small intestines
and proliferating bile-ducts [19–21]. Increased Gro-γ expres-
sion was observed in CF foetal lungs, specifically in
monocytes and endothelial cells (Fig. 1G and H). In contrast,
Gro-β expression was identical in CF and control foetal lungs
(Fig. 1E and F). The role ofmonocytes in CF inflammation has
been suggested by Zaman et al. [22] who showed that basal
and LPS-induced IL-8 expression by CF monocytes is higher
than IL-8 secretion by normal monocytes.
The enzyme Cox-2 plays a central role in inflammation
[23–25]. Its over-expression was observed in bronchiolar
epithelial cells from CF lungs in comparison with develop-
ment-matched control lungs (Fig. 1C and D). MMP-1 was
found to be expressed in the CF pulmonary cartilage while it
was not detected in the cartilage of control foetuses (Fig. 1I
and J). Although an over-expression of MMP-1 has never
been described in CF patients, increased levels of this matrix
metalloproteinase is associated with several human diseases
such as cancer, autoimmune disorders, COPD and asthma
[26–28]. Moreover, an increasedMMP-1 expression has also
been shown in cartilage tissue of patients with osteoarthritis
[29].
Interestingly, despite of the absence of any histological
sign of inflammation, the CF foetal lungs thus over-expressed
MMP-1, Groγ, ICAM-1 and Cox-2, four molecules known to
be regulated by NF-κB [30–33]. NF-κB is an inducible
transcription factor that plays a central role in the regulation
of immune and inflammatory responses. While NF-κB is
required for cell survival and immunity, prolonged NF-κB
activation seems essential for the persistence of chronic
inflammatory diseases [34–36]. Constitutive activation of
this inflammatory transcription factor has been already
associated with CF [10–12]. We therefore determined
whether the CF foetal lungs displayed higher NF-κB
activation than control lungs. For this purpose, subcellular
immunolocalization analyses of p65were performed (Fig. 2A
and B); these analyses revealed a cytoplasmic localization of
p65 both in CF (Fig. 2B) and non-CF (Fig. 2A) lung cells. A
nuclear staining of p65 was only observed in the CF lung
epithelial cells (Fig. 2B). This result indicated that NF-κB is
activated in the CF foetal lungs. Our findings therefore
suggest that, already in CF foetal lungs, CFTR dysfunction
leads to NF-κB activation which enhances the expression of
specific pro-inflammatory proteins.
To our knowledge, this is the first report of in vivo
evidence for a pro-inflammatory process initiated very early
in the pathogenesis of cystic fibrosis before any infection.
This intrinsic inflammation is probably mild and likely re-
sults from a deregulated NF-κB activation which may be the
starting point for subsequent pathological pulmonary
dysfunction. The identification of the molecular mechanisms
linking mutated CFTR to the NF-κB activation pathway will
be crucial to define novel anti-inflammatory strategies for CF
patients. Indeed, as inflammation and neutrophil influx are
two major pathophysiological features of pulmonary CF
disease, any therapy that reduces the production of pro-
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Fig. 2. Nuclear localization of p65 in the CF foetal lung. Control foetal lungs (A) andΔF508-CFTR foetal lungs (B) were stained for p65 (A, B) localization. Cell
nuclear DNAwas stained with TOTO-3 (C–D). Original magnification, ×63.
307C. Verhaeghe et al. / Journal of Cystic Fibrosis 6 (2007) 304–308inflammatory molecules could, if applied early, prevent the
chronic inflammation and the degradation of lung function.
Many NF-κB inhibitors are currently being developed
and tested in various conditions. Our observations and
previous reports provide a rationale for further studies on
in vivo NF-κB activity before infection in CF lungs and
possibly for clinical trials with specific and tolerable NF-κB
inhibitors.
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